Tumor tissue or cytology samples are preferred for RET fusion testing. If it cannot be obtained or is insufficient, peripheral blood, pleural effusion, or cerebrospinal fluid can be considered for ctDNA testing in advanced NSCLC patients. Here, RET is linked to non-small cell lung carcinoma.